Previous studies showed that short term exposure of cells to high glucose destabilized protein kinase C (PKC) II mRNA, whereas PKCI mRNA levels remained unaltered. Because PKC mRNAs share common sequences other than the PKCII exon encoding a different carboxyl terminus, we examined PKCII mRNA for a cis-acting region that could confer glucose-induced destabilization. A -globin/growth hormone reporter con struct containing the PKCII exon was transfected into human aorta and rat vascular smooth muscle cells (A10) to follow glucose-induced destabilization. Glucose (25 mM) exposure destabilized PKCII chimeric mRNA but not control mRNA. Deletion analysis and electrophoretic mobility shift assays followed by UV cross-linking experiments demonstrated that a region introduced by inclusion of the II exon was required to confer destabilization. Although a cis-acting element mapped to 38 nucleotides within the II exon was necessary to bestow destabilization, it was not sufficient by itself to confer complete mRNA destabilization. Yet, in intact cells antisense oligonucleotides complementary to this region blocked glucose-induced destabilization. These results suggest that this region must function in context with other sequence elements created by exon inclusion involved in affecting mRNA stability. In summary, inclusion of an exon that encodes PKCII mRNA introduces a cisacting region that confers destabilization to the mRNA in response to glucose.Protein kinase C (PKC), 1 a serine/threonine kinase, comprises a family of 12 isozymes that have been implicated in signaling pathways affecting cellular processes such as cell proliferation and differentiation, apoptosis, tumor promotion, transcriptional activation, and hormone production (1). The PKC isozymes exhibit differential cellular distribution and substrate specificity. The conventional PKC isozymes, which are Ca 2ϩ -dependent and activated by phospholipid and diacylglycerol, include PKC␣, PKCI, PKCII, and PKC␥. PKCI and PKCII are encoded by the same gene, and are translated from alternatively spliced products of PKC pre-mRNA. The inclusion of the PKCII exon in the 3Ј-region through alternative splicing results in the PKCII mRNA. This pattern of splicing generates a stop codon at the II-I boundary such that the I exon, with its coding sequence and 3Ј-UTR, now becomes the 3Ј-UTR of PKCII mRNA (Fig. 1). As a result, the PKCI and PKCII mRNAs differ only by the sequence of the included PKCII exon, and the proteins differ only by their carboxylterminal 50 -52 amino acids, respectively (1).We have previously shown that acute hyperglycemia downregulates PKCII, but not PKCI, at the mRNA and protein levels in vascular smooth muscle cells (2). To understand the mechanism by which elevated glucose down-regulates PKCII expression in vascular smooth muscle cells, earlier studies were carried out to determine at what level suppression of PKCII expression occurred. These studies clearly demonstrated that high glucose (10 -30 mM), at levels that commonly occ...